| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0196-9781(02)00251-6 |
| P698 | PubMed publication ID | 12535700 |
| P50 | author | Joseph Takahashi | Q6287342 |
| Shahrad Taheri | Q43145465 | ||
| P2093 | author name string | Lin L | |
| Lin X | |||
| Mignot E | |||
| Lovenberg TW | |||
| Shiba T | |||
| Nishino S | |||
| Yanai K | |||
| Koehl M | |||
| Uhl G | |||
| Vitaterna M | |||
| Wisor J | |||
| Wurts S | |||
| P2860 | cites work | Heterozygous VMAT2 knockout mice display prolonged QT intervals: possible contributions to sudden death | Q48090706 |
| Distribution and quantification of immunoreactive orexin A in rat tissues. | Q48112935 | ||
| Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus | Q48136296 | ||
| Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors. | Q48394310 | ||
| Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities | Q48680835 | ||
| Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. | Q48681122 | ||
| Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy | Q48683622 | ||
| Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone | Q48721865 | ||
| Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. | Q48731559 | ||
| The selective histamine H1-receptor agonist 2-(3-trifluoromethylphenyl)histamine increases waking in the rat. | Q48829552 | ||
| Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the neuronal isoform of the vesicular monoamine transporter. | Q52019491 | ||
| Multi-phenotype behavioral characterization of inbred strains derived from wild stocks of Mus musculus. | Q52166430 | ||
| Hypocretin (orexin) deficiency in human narcolepsy. | Q55033530 | ||
| Differential expression of two vesicular monoamine transporters | Q72038012 | ||
| Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior | Q24315738 | ||
| The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity | Q24317782 | ||
| The circadian clock mutation alters sleep homeostasis in the mouse | Q28142164 | ||
| The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene | Q28142783 | ||
| A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains | Q28145391 | ||
| Hypocretin/orexin, sleep and narcolepsy | Q28187653 | ||
| To eat or to sleep? Orexin in the regulation of feeding and wakefulness | Q28209925 | ||
| VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity | Q28512294 | ||
| Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation | Q29615680 | ||
| Neurons containing hypocretin (orexin) project to multiple neuronal systems | Q29619641 | ||
| The physiology of brain histamine. | Q31875011 | ||
| Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. | Q31883018 | ||
| Fos expression in orexin neurons varies with behavioral state. | Q32062017 | ||
| Dopaminergic role in stimulant-induced wakefulness. | Q32062046 | ||
| The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. | Q33910875 | ||
| Reduced number of hypocretin neurons in human narcolepsy | Q33923479 | ||
| Arousal effect of orexin A depends on activation of the histaminergic system | Q33934848 | ||
| A commentary on the neurobiology of the hypocretin/orexin system | Q34099493 | ||
| Behavioral characterization of mice lacking histamine H(3) receptors. | Q34140174 | ||
| Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives | Q34298123 | ||
| Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors | Q36692674 | ||
| Characterization of orexins (hypocretins) and melanin-concentrating hormone in genetically obese mice | Q38292294 | ||
| Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus | Q38303103 | ||
| Effects of food restriction on the hypothalamic prepro-orexin gene expression in genetically obese mice | Q38313440 | ||
| Down regulation of the prepro-orexin gene expression in genetically obese mice | Q38327773 | ||
| Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. | Q39758343 | ||
| CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. | Q40670797 | ||
| Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines | Q40815636 | ||
| Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile | Q42281719 | ||
| Distribution of orexin neurons in the adult rat brain | Q42471901 | ||
| Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs | Q43780972 | ||
| Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. | Q43805360 | ||
| Orexins (hypocretins) directly excite tuberomammillary neurons | Q43808699 | ||
| Orexins activate histaminergic neurons via the orexin 2 receptor | Q43866866 | ||
| P433 | issue | 12 | |
| P921 | main subject | circadian rhythm | Q208353 |
| P304 | page(s) | 2203-2211 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Peptides | Q7166533 |
| P1476 | title | Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background | |
| P478 | volume | 23 |
| Q42015698 | Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine |
| Q48468531 | Defective carbohydrate metabolism in mice homozygous for the tubby mutation |
| Q36756384 | Histamine and schizophrenia |
| Q33401580 | IGFBP3 colocalizes with and regulates hypocretin (orexin) |
| Q38534913 | Interactions of the histamine and hypocretin systems in CNS disorders. |
| Q38284819 | Interactions of the orexin/hypocretin neurones and the histaminergic system |
| Q34485538 | Involvement of spinal orexin A in the electroacupuncture analgesia in a rat model of post-laparotomy pain |
| Q30485386 | Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice |
| Q45233267 | Orexin A promotes histamine, but not norepinephrine or serotonin, release in frontal cortex of mice. |
| Q24650737 | Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models |
| Q41153530 | Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity |
| Q34451399 | Sleep disorders, obesity, and aging: the role of orexin |
| Q36681452 | Sleep is increased by weight gain and decreased by weight loss in mice. |
| Q33947805 | The diurnal rhythm of hypocretin in young and old F344 rats |
| Q38115678 | The histaminergic network in the brain: basic organization and role in disease |
| Q30557296 | Upregulation of gene expression in reward-modulatory striatal opioid systems by sleep loss |
Search more.